A device for delivering medication directly to the eye
Lens Capsule Based Extended Drug Delivery Device
['FUNDING_CAREER'] · STANFORD UNIVERSITY · NIH-11033844
This study is testing a new device that delivers medicine directly to the eye to help people with noninfectious uveitis, aiming to make treatment safer and easier by reducing the need for medications that can cause unwanted side effects.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | STANFORD UNIVERSITY (nih funded) |
| Locations | 1 site (STANFORD, UNITED STATES) |
| Trial ID | NIH-11033844 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a new device that can deliver medication directly to the eye to treat noninfectious uveitis, a condition that causes inflammation. The approach involves creating a refillable lens capsule that can release biologics and immune-modulating peptides over an extended period, reducing the need for systemic medications that often have severe side effects. By using this innovative delivery method, the research aims to provide a safer and more effective treatment option for patients suffering from ocular inflammation.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with noninfectious uveitis who require ongoing treatment for ocular inflammation.
Not a fit: Patients with infectious uveitis or those who do not require long-term treatment for ocular inflammation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with a safer, long-term treatment option for noninfectious uveitis that minimizes side effects compared to current therapies.
How similar studies have performed: Previous research has shown promise in localized drug delivery systems for ocular conditions, suggesting that this approach could be effective.
Where this research is happening
STANFORD, UNITED STATES
- STANFORD UNIVERSITY — STANFORD, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DEBOER, CHARLES MENO THEODORE — STANFORD UNIVERSITY
- Study coordinator: DEBOER, CHARLES MENO THEODORE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.